Linked e-resources
Details
Table of Contents
Antipsychotics and the Dopamine-Serotonin Connection
GLYT1 Inhibitors: From Hits to Clinical Candidates
Metabotropic Glutamate Receptor 2 Activators
Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders
Muscarinic Acetylcholine Receptor Activators
Nicotinic Acetylcholine Receptor Modulators
The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
GLYT1 Inhibitors: From Hits to Clinical Candidates
Metabotropic Glutamate Receptor 2 Activators
Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders
Muscarinic Acetylcholine Receptor Activators
Nicotinic Acetylcholine Receptor Modulators
The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.